In High-Grade Prostate Cancer, Low PSA Levels May Raise Mortality Risk

In High-Grade Prostate Cancer, Low PSA Levels May Raise Mortality Risk
Among patients with high-grade prostate cancer, new research has found that very low prostate-specific antigen (PSA) levels may be associated with a higher risk for cancer-specific death. The research, presented in a paper titled “Association of very low prostate-specific antigen levels with increased cancer-specific death in men with high-grade prostate cancer,” was published in the journal Cancer.

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Tagged , , , .

Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.

2 comments

    • Tim Bossie says:

      Hi Gerard, thank you for the question. We at PCNews can’t answer that with any definitive advice. However, we can encourage you to talk with your doctor about the next steps.

Leave a Comment

Your email address will not be published. Required fields are marked *